Clinical Trial Update: Impact of AferBio® on Quality of Life and Chemotherapy Toxicity in Lung Cancer Patients [NA]

View source ↗

Summary

This clinical trial update reports on the evaluation of AferBio for improving quality of life and reducing chemotherapy toxicity in lung cancer patients; curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• AferBio

Snippet

Sponsor: Barretos Cancer Hospital | Conditions: Quality of Life, Infection | NA | Status: UNKNOWN